| [613] | 1 | DVBCWSD5 ;ALB/RLC SKIN DISEASES (Other Than Scars) WKS TEXT - 1 ; 11/20/02 4:43pm
 | 
|---|
 | 2 |  ;;2.7;AMIE;**81**;Apr 10, 1995
 | 
|---|
 | 3 |  ;
 | 
|---|
 | 4 |  ;
 | 
|---|
 | 5 | TXT ;
 | 
|---|
 | 6 |  ;;A.  Review of Medical Records:
 | 
|---|
 | 7 |  ;;
 | 
|---|
 | 8 |  ;;
 | 
|---|
 | 9 |  ;;
 | 
|---|
 | 10 |  ;;B.  Medical History (Subjective Complaints):
 | 
|---|
 | 11 |  ;;
 | 
|---|
 | 12 |  ;;    1.  Describe onset and course of disease, whether it is
 | 
|---|
 | 13 |  ;;        intermittent or constant, and whether it is progressive.
 | 
|---|
 | 14 |  ;;
 | 
|---|
 | 15 |  ;;
 | 
|---|
 | 16 |  ;;    2.  Describe current treatment.  Specify the medication(s) 
 | 
|---|
 | 17 |  ;;        used and dosage.  State whether any is a corticosteroid
 | 
|---|
 | 18 |  ;;        or other immunosuppresive drug.  State whether medications
 | 
|---|
 | 19 |  ;;        used are systemic or topical.  Describe whether intensive
 | 
|---|
 | 20 |  ;;        light therapy, UVB, PUVA, or electron beam therapy are used. 
 | 
|---|
 | 21 |  ;;
 | 
|---|
 | 22 |  ;;
 | 
|---|
 | 23 |  ;;    3.  For EACH treatment, report the frequency of use and duration
 | 
|---|
 | 24 |  ;;        of treatment during the past 12-month period.
 | 
|---|
 | 25 |  ;;
 | 
|---|
 | 26 |  ;;
 | 
|---|
 | 27 |  ;;    4.  Describe any side effects of treatment.
 | 
|---|
 | 28 |  ;;
 | 
|---|
 | 29 |  ;;
 | 
|---|
 | 30 |  ;;    5.  Describe local (skin) symptoms and any systemic symptoms,
 | 
|---|
 | 31 |  ;;        such as fever or weight loss.
 | 
|---|
 | 32 |  ;;
 | 
|---|
 | 33 |  ;;
 | 
|---|
 | 34 |  ;;    6.  For malignant neoplasms of skin, additionally describe
 | 
|---|
 | 35 |  ;;        all treatment, including date and type of last treatment.
 | 
|---|
 | 36 |  ;;
 | 
|---|
 | 37 |  ;;
 | 
|---|
 | 38 |  ;;    7.  For benign neoplasms of skin, additionally describe any
 | 
|---|
 | 39 |  ;;        impairment of function.
 | 
|---|
 | 40 |  ;;
 | 
|---|
 | 41 |  ;;
 | 
|---|
 | 42 |  ;;    8.  For urticaria, primary cutaneous vasculitis, and 
 | 
|---|
 | 43 |  ;;        erythema multiforme, additionally describe the number of
 | 
|---|
 | 44 |  ;;        episodes during the past 12-month period, whether the 
 | 
|---|
 | 45 |  ;;        episodes are debilitating, how they are treated, and 
 | 
|---|
 | 46 |  ;;        whether they respond to treatment.
 | 
|---|
 | 47 |  ;;
 | 
|---|
 | 48 |  ;;C.  Physical Examination (Objective Findings):
 | 
|---|
 | 49 |  ;;
 | 
|---|
 | 50 |  ;;    1.  For dermatitis, eczema, leishmaniasis, lupus, dermatophytosis,
 | 
|---|
 | 51 |  ;;        bullous disorders, psoriasis, infections of the skin,
 | 
|---|
 | 52 |  ;;        cutaneous manifestations of collagen vascular diseases, and
 | 
|---|
 | 53 |  ;;        papulosquamous disorders, report extent of disease.  Specify
 | 
|---|
 | 54 |  ;;        if any exposed areas (head, face, neck and hands) are
 | 
|---|
 | 55 |  ;;        affected.  Provide the percent affected of exposed areas.
 | 
|---|
 | 56 |  ;;        Provide the percent affected of the entire body.
 | 
|---|
 | 57 |  ;;
 | 
|---|
 | 58 |  ;;
 | 
|---|
 | 59 |  ;;    2.  If there is scarring or disfigurement, follow the "Scars"
 | 
|---|
 | 60 |  ;;        worksheet in addition to this one.
 | 
|---|
 | 61 |  ;;
 | 
|---|
 | 62 |  ;;
 | 
|---|
 | 63 |  ;;    3.  For acne or chloracne, describe whether the acne is 
 | 
|---|
 | 64 |  ;;        superficial (with comedones, papules, pustules, superficial
 | 
|---|
 | 65 |  ;;        cysts) or deep (with deep inflamed nodules and pus-filled
 | 
|---|
 | 66 |  ;;        cysts), which areas of the body are affected, and, 
 | 
|---|
 | 67 |  ;;        specifically, the PERCENT OF FACE AND NECK affected.
 | 
|---|
 | 68 |  ;;
 | 
|---|
 | 69 |  ;;
 | 
|---|
 | 70 |  ;;    4.  For scarring alopecia, describe the PERCENT OF THE SCALP  
 | 
|---|
 | 71 |  ;;        that is affected.
 | 
|---|
 | 72 |  ;;
 | 
|---|
 | 73 |  ;;
 | 
|---|
 | 74 |  ;;    5.  For alopecia areata, describe whether there is loss of all
 | 
|---|
 | 75 |  ;;        body hair or whether loss of hair is limited to the scalp 
 | 
|---|
 | 76 |  ;;        and face.
 | 
|---|
 | 77 |  ;;
 | 
|---|
 | 78 |  ;;
 | 
|---|
 | 79 |  ;;    6.  For hyperhidrosis, state whether veteran is able to handle
 | 
|---|
 | 80 |  ;;        paper or tools after therapy, or is unable to handle paper
 | 
|---|
 | 81 |  ;;        or tools because of moisture and is unresponsive to therapy.
 | 
|---|
 | 82 |  ;;
 | 
|---|
 | 83 |  ;;D.  Diagnostic and Clinical Tests:
 | 
|---|
 | 84 |  ;;
 | 
|---|
 | 85 |  ;;    1.  Biopsy, scrapings if indicated.
 | 
|---|
 | 86 |  ;;    2.  Include results of all diagnostic and clinical tests conducted
 | 
|---|
 | 87 |  ;;        in the examination report.
 | 
|---|
 | 88 |  ;;    3.  With disfigurement or disfiguring scar of head, face, or 
 | 
|---|
 | 89 |  ;;        neck, submit COLOR PHOTOGRAPHS. 
 | 
|---|
 | 90 |  ;;    4.  Test for hypoproteinemia if examining for exfoliative
 | 
|---|
 | 91 |  ;;        dermatitis (erythroderma).
 | 
|---|
 | 92 |  ;;
 | 
|---|
 | 93 |  ;;E.  Diagnosis:
 | 
|---|
 | 94 |  ;;
 | 
|---|
 | 95 |  ;;
 | 
|---|
 | 96 |  ;;Signature:                             Date:
 | 
|---|
 | 97 |  ;;END
 | 
|---|